South & Central America Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
The South & Central America Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 82.5 billion by 2031, up from US$ 52.5 billion in 2024. This growth represents a compound annual growth rate (CAGR) of 6.7% from 2025 to 2031.
Executive Summary and Market Analysis
The increasing awareness of healthcare and improved access to medical facilities are key drivers behind the rising demand for prescription medications in South and Central America. Economic growth across various countries has led to an expanding middle class, allowing more individuals to afford better healthcare services and pharmaceuticals. Additionally, the prevalence of chronic diseases, including diabetes, cardiovascular conditions, and respiratory disorders, has necessitated long-term medication management, further fueling the demand for prescription drugs.
Governments in the region are actively investing in healthcare infrastructure and expanding insurance coverage, which enhances the accessibility of prescription medications. The local pharmaceutical manufacturing capabilities are also on the rise, supported by increased foreign direct investment, which not only improves drug availability but also helps in reducing costs. Urbanization and lifestyle changes have led to a higher incidence of lifestyle-related illnesses, contributing to the growing consumption of prescription drugs.
Regulatory reforms aimed at streamlining drug approval processes have encouraged global pharmaceutical companies to enter the market, thereby increasing the variety of available medications. Technological advancements in drug development and distribution, including the rise of e-pharmacies, have made it easier for patients to obtain necessary medications. These factors collectively create a favorable environment for the expansion of the prescription drugs market in South and Central America.
Strategic Insights
Market Segmentation Analysis
The South & Central America Prescription Drugs Market can be segmented based on various criteria:
The prescription drugs market is witnessing various strategic developments, including product approvals, launches, and collaborations aimed at addressing chronic disorders. Notable recent developments include:
Country Insights
The market is also analyzed by country, with Brazil, Argentina, and the Rest of South & Central America being the primary segments. Brazil is the largest market, driven by a robust healthcare infrastructure, a high prevalence of chronic diseases, and a growing middle class with better access to medical services. Chronic conditions such as hypertension, cancer, and diabetes are prevalent, necessitating effective pharmaceutical interventions. For instance, approximately 24% of the adult population in Brazil suffers from hypertension, and there were over 627,000 reported cancer cases in 2022, highlighting the urgent need for effective prescription medications.
Company Profiles
Key players in the Prescription Drugs Market include GSK Plc, F. Hoffmann-La Roche Ltd, Pfizer Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG, Sanofi SA, Johnson & Johnson, AstraZeneca Plc, AbbVie Inc, and Eli Lilly and Co. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products to consumers.
In summary, the South & Central America Prescription Drugs Market is poised for substantial growth, driven by increasing healthcare access, rising chronic disease prevalence, and strategic initiatives by key players in the pharmaceutical industry.
Executive Summary and Market Analysis
The increasing awareness of healthcare and improved access to medical facilities are key drivers behind the rising demand for prescription medications in South and Central America. Economic growth across various countries has led to an expanding middle class, allowing more individuals to afford better healthcare services and pharmaceuticals. Additionally, the prevalence of chronic diseases, including diabetes, cardiovascular conditions, and respiratory disorders, has necessitated long-term medication management, further fueling the demand for prescription drugs.
Governments in the region are actively investing in healthcare infrastructure and expanding insurance coverage, which enhances the accessibility of prescription medications. The local pharmaceutical manufacturing capabilities are also on the rise, supported by increased foreign direct investment, which not only improves drug availability but also helps in reducing costs. Urbanization and lifestyle changes have led to a higher incidence of lifestyle-related illnesses, contributing to the growing consumption of prescription drugs.
Regulatory reforms aimed at streamlining drug approval processes have encouraged global pharmaceutical companies to enter the market, thereby increasing the variety of available medications. Technological advancements in drug development and distribution, including the rise of e-pharmacies, have made it easier for patients to obtain necessary medications. These factors collectively create a favorable environment for the expansion of the prescription drugs market in South and Central America.
Strategic Insights
Market Segmentation Analysis
The South & Central America Prescription Drugs Market can be segmented based on various criteria:
- By Product Type: The market is divided into Branded and Generic drugs, with Branded drugs holding the largest market share in 2024.
- By Drug Type: It is further segmented into Small Molecule drugs and Biologics/Biosimilars, where Small Molecule drugs dominate the market.
- By Therapeutic Area: The market is categorized into Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others, with Oncology leading in market share.
- By Route of Administration: This includes Oral, Injectable, Topical, and Others, with Oral administration being the most prevalent.
- By Distribution Channel: The market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies, where Hospital Pharmacies hold the largest share.
The prescription drugs market is witnessing various strategic developments, including product approvals, launches, and collaborations aimed at addressing chronic disorders. Notable recent developments include:
- In October 2022, Pfizer Inc. acquired Biohaven Pharmaceutical Holding Company Ltd, enhancing its portfolio with a breakthrough treatment for migraines.
- In March 2025, Hypera Pharma announced plans to launch a generic formulation of semaglutide in Brazil by 2026, aimed at improving access to diabetes and obesity treatments.
Country Insights
The market is also analyzed by country, with Brazil, Argentina, and the Rest of South & Central America being the primary segments. Brazil is the largest market, driven by a robust healthcare infrastructure, a high prevalence of chronic diseases, and a growing middle class with better access to medical services. Chronic conditions such as hypertension, cancer, and diabetes are prevalent, necessitating effective pharmaceutical interventions. For instance, approximately 24% of the adult population in Brazil suffers from hypertension, and there were over 627,000 reported cancer cases in 2022, highlighting the urgent need for effective prescription medications.
Company Profiles
Key players in the Prescription Drugs Market include GSK Plc, F. Hoffmann-La Roche Ltd, Pfizer Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG, Sanofi SA, Johnson & Johnson, AstraZeneca Plc, AbbVie Inc, and Eli Lilly and Co. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products to consumers.
In summary, the South & Central America Prescription Drugs Market is poised for substantial growth, driven by increasing healthcare access, rising chronic disease prevalence, and strategic initiatives by key players in the pharmaceutical industry.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. PRESCRIPTION DRUGS MARKET LANDSCAPE
4.1 PEST Analysis
5. SOUTH & CENTRAL AMERICA PRESCRIPTION DRUGS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. PRESCRIPTION DRUGS MARKET - SOUTH & CENTRAL AMERICA MARKET ANALYSIS
6.1 South & Central America Prescription Drugs Market Revenue (US$ Billion), 2024 - 2031
6.2 South & Central America Prescription Drugs Market Forecast and Analysis
7. SOUTH & CENTRAL AMERICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY PRODUCT TYPE
7.1 Branded
7.1.1 Overview
7.1.2 Branded: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
7.2 Generics
7.2.1 Overview
7.2.2 Generics: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
8. SOUTH & CENTRAL AMERICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY DRUG TYPE
8.1 Small Molecule
8.1.1 Overview
8.1.2 Small Molecule: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
8.2 Biologics and Biosimilar
8.2.1 Overview
8.2.2 Biologics and Biosimilar: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9. SOUTH & CENTRAL AMERICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY THERAPEUTIC AREA
9.1 Oncology
9.1.1 Overview
9.1.2 Oncology: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.2 Cardiovascular Diseases
9.2.1 Overview
9.2.2 Cardiovascular Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.3 Neurological Diseases
9.3.1 Overview
9.3.2 Neurological Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.4 Metabolic Diseases
9.4.1 Overview
9.4.2 Metabolic Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.5 Respiratory Diseases
9.5.1 Overview
9.5.2 Respiratory Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.6 Immunology
9.6.1 Overview
9.6.2 Immunology: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.7 Others
9.7.1 Overview
9.7.2 Others: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10. SOUTH & CENTRAL AMERICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
10.1 Oral
10.1.1 Overview
10.1.2 Oral: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.2 Injectable
10.2.1 Overview
10.2.2 Injectable: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.3 Topical
10.3.1 Overview
10.3.2 Topical: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.4 Others
10.4.1 Overview
10.4.2 Others: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11. SOUTH & CENTRAL AMERICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY DISTRIBUTION CHANNEL
11.1 Hospital Pharmacies
11.1.1 Overview
11.1.2 Hospital Pharmacies: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11.2 Retail Pharmacies
11.2.1 Overview
11.2.2 Retail Pharmacies: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11.3 Online Pharmacies
11.3.1 Overview
11.3.2 Online Pharmacies: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12. SOUTH & CENTRAL AMERICA PRESCRIPTION DRUGS MARKET - COUNTRY ANALYSIS
12.1 South & Central America
12.1.1 South & Central America Prescription Drugs Market Revenue and Forecast and Analysis - by Country
12.1.1.1 South & Central America Prescription Drugs Market Revenue and Forecast and Analysis - by Country
12.1.2.2 Brazil: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.1.2.2.1 Brazil: South & Central America Prescription Drugs Market Share - by Product Type
12.1.2.2.2 Brazil: South & Central America Prescription Drugs Market Share - by Drug Type
12.1.2.2.3 Brazil: South & Central America Prescription Drugs Market Share - by Therapeutic Area
12.1.2.2.4 Brazil: South & Central America Prescription Drugs Market Share - by Route Of Administration
12.1.2.2.5 Brazil: South & Central America Prescription Drugs Market Share - by Distribution Channel
12.2.3.3 Argentina: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.2.3.3.1 Argentina: South & Central America Prescription Drugs Market Share - by Product Type
12.2.3.3.2 Argentina: South & Central America Prescription Drugs Market Share - by Drug Type
12.2.3.3.3 Argentina: South & Central America Prescription Drugs Market Share - by Therapeutic Area
12.2.3.3.4 Argentina: South & Central America Prescription Drugs Market Share - by Route Of Administration
12.2.3.3.5 Argentina: South & Central America Prescription Drugs Market Share - by Distribution Channel
12.3.4.4 Rest of South & Central America: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.3.4.4.1 Rest of South & Central America: South & Central America Prescription Drugs Market Share - by Product Type
12.3.4.4.2 Rest of South & Central America: South & Central America Prescription Drugs Market Share - by Drug Type
12.3.4.4.3 Rest of South & Central America: South & Central America Prescription Drugs Market Share - by Therapeutic Area
12.3.4.4.4 Rest of South & Central America: South & Central America Prescription Drugs Market Share - by Route Of Administration
12.3.4.4.5 Rest of South & Central America: South & Central America Prescription Drugs Market Share - by Distribution Channel
13 COMPETITIVE LANDSCAPE
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning & Concentration
14 INDUSTRY LANDSCAPE
14.1 Overview
14.2 New Product Development
14.3 Merger and Acquisition
14.4 Other Strategic Developments
15 COMPANY PROFILES
15.1 GSK Plc
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. Hoffmann-La Roche Ltd
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Pfizer Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Merck & Co Inc
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Teva Pharmaceutical Industries Ltd
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Novartis AG
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Sanofi SA
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Johnson & Johnson
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 AstraZeneca Plc
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 AbbVie Inc
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Eli Lilly and Co
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 ESTEVE
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. PRESCRIPTION DRUGS MARKET LANDSCAPE
4.1 PEST Analysis
5. SOUTH & CENTRAL AMERICA PRESCRIPTION DRUGS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. PRESCRIPTION DRUGS MARKET - SOUTH & CENTRAL AMERICA MARKET ANALYSIS
6.1 South & Central America Prescription Drugs Market Revenue (US$ Billion), 2024 - 2031
6.2 South & Central America Prescription Drugs Market Forecast and Analysis
7. SOUTH & CENTRAL AMERICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY PRODUCT TYPE
7.1 Branded
7.1.1 Overview
7.1.2 Branded: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
7.2 Generics
7.2.1 Overview
7.2.2 Generics: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
8. SOUTH & CENTRAL AMERICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY DRUG TYPE
8.1 Small Molecule
8.1.1 Overview
8.1.2 Small Molecule: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
8.2 Biologics and Biosimilar
8.2.1 Overview
8.2.2 Biologics and Biosimilar: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9. SOUTH & CENTRAL AMERICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY THERAPEUTIC AREA
9.1 Oncology
9.1.1 Overview
9.1.2 Oncology: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.2 Cardiovascular Diseases
9.2.1 Overview
9.2.2 Cardiovascular Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.3 Neurological Diseases
9.3.1 Overview
9.3.2 Neurological Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.4 Metabolic Diseases
9.4.1 Overview
9.4.2 Metabolic Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.5 Respiratory Diseases
9.5.1 Overview
9.5.2 Respiratory Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.6 Immunology
9.6.1 Overview
9.6.2 Immunology: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.7 Others
9.7.1 Overview
9.7.2 Others: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10. SOUTH & CENTRAL AMERICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
10.1 Oral
10.1.1 Overview
10.1.2 Oral: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.2 Injectable
10.2.1 Overview
10.2.2 Injectable: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.3 Topical
10.3.1 Overview
10.3.2 Topical: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.4 Others
10.4.1 Overview
10.4.2 Others: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11. SOUTH & CENTRAL AMERICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY DISTRIBUTION CHANNEL
11.1 Hospital Pharmacies
11.1.1 Overview
11.1.2 Hospital Pharmacies: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11.2 Retail Pharmacies
11.2.1 Overview
11.2.2 Retail Pharmacies: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11.3 Online Pharmacies
11.3.1 Overview
11.3.2 Online Pharmacies: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12. SOUTH & CENTRAL AMERICA PRESCRIPTION DRUGS MARKET - COUNTRY ANALYSIS
12.1 South & Central America
12.1.1 South & Central America Prescription Drugs Market Revenue and Forecast and Analysis - by Country
12.1.1.1 South & Central America Prescription Drugs Market Revenue and Forecast and Analysis - by Country
12.1.2.2 Brazil: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.1.2.2.1 Brazil: South & Central America Prescription Drugs Market Share - by Product Type
12.1.2.2.2 Brazil: South & Central America Prescription Drugs Market Share - by Drug Type
12.1.2.2.3 Brazil: South & Central America Prescription Drugs Market Share - by Therapeutic Area
12.1.2.2.4 Brazil: South & Central America Prescription Drugs Market Share - by Route Of Administration
12.1.2.2.5 Brazil: South & Central America Prescription Drugs Market Share - by Distribution Channel
12.2.3.3 Argentina: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.2.3.3.1 Argentina: South & Central America Prescription Drugs Market Share - by Product Type
12.2.3.3.2 Argentina: South & Central America Prescription Drugs Market Share - by Drug Type
12.2.3.3.3 Argentina: South & Central America Prescription Drugs Market Share - by Therapeutic Area
12.2.3.3.4 Argentina: South & Central America Prescription Drugs Market Share - by Route Of Administration
12.2.3.3.5 Argentina: South & Central America Prescription Drugs Market Share - by Distribution Channel
12.3.4.4 Rest of South & Central America: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.3.4.4.1 Rest of South & Central America: South & Central America Prescription Drugs Market Share - by Product Type
12.3.4.4.2 Rest of South & Central America: South & Central America Prescription Drugs Market Share - by Drug Type
12.3.4.4.3 Rest of South & Central America: South & Central America Prescription Drugs Market Share - by Therapeutic Area
12.3.4.4.4 Rest of South & Central America: South & Central America Prescription Drugs Market Share - by Route Of Administration
12.3.4.4.5 Rest of South & Central America: South & Central America Prescription Drugs Market Share - by Distribution Channel
13 COMPETITIVE LANDSCAPE
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning & Concentration
14 INDUSTRY LANDSCAPE
14.1 Overview
14.2 New Product Development
14.3 Merger and Acquisition
14.4 Other Strategic Developments
15 COMPANY PROFILES
15.1 GSK Plc
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. Hoffmann-La Roche Ltd
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Pfizer Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Merck & Co Inc
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Teva Pharmaceutical Industries Ltd
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Novartis AG
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Sanofi SA
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Johnson & Johnson
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 AstraZeneca Plc
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 AbbVie Inc
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Eli Lilly and Co
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 ESTEVE
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
LIST OF TABLES
Table 1. South & Central America Prescription Drugs Market Segmentation
Table 3. South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Table 4. South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 5. South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 6. South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 7. South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 8. South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 9. South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Country
Table 10. Brazil: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 11. Brazil: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 12. Brazil: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 13. Brazil: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 14. Brazil: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 15. Argentina: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 16. Argentina: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 17. Argentina: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 18. Argentina: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 19. Argentina: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 20. Rest of South & Central America: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 21. Rest of South & Central America: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 22. Rest of South & Central America: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 23. Rest of South & Central America: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 24. Rest of South & Central America: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 25. Heat Map Analysis by Key Players
Table 1. South & Central America Prescription Drugs Market Segmentation
Table 3. South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Table 4. South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 5. South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 6. South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 7. South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 8. South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 9. South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Country
Table 10. Brazil: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 11. Brazil: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 12. Brazil: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 13. Brazil: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 14. Brazil: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 15. Argentina: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 16. Argentina: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 17. Argentina: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 18. Argentina: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 19. Argentina: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 20. Rest of South & Central America: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 21. Rest of South & Central America: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 22. Rest of South & Central America: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 23. Rest of South & Central America: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 24. Rest of South & Central America: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 25. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. South & Central America Prescription Drugs Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. South & Central America Prescription Drugs Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. South & Central America Prescription Drugs Market Revenue (US$ Billion), 2024 - 2031
Figure 7. South & Central America Prescription Drugs Market Share (%) - by Product Type, 2024 and 2031
Figure 8. Branded: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 9. Generics: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 10. South & Central America Prescription Drugs Market Share (%) - by Drug Type, 2024 and 2031
Figure 11. Small Molecule: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 12. Biologics and Biosimilar: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 13. South & Central America Prescription Drugs Market Share (%) - by Therapeutic Area, 2024 and 2031
Figure 14. Oncology: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 15. Cardiovascular Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 16. Neurological Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 17. Metabolic Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 18. Respiratory Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 19. Immunology: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 20. Others: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 21. South & Central America Prescription Drugs Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 22. Oral: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 23. Injectable: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 24. Topical: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 25. Others: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 26. South & Central America Prescription Drugs Market Share (%) - by Distribution Channel, 2024 and 2031
Figure 27. Hospital Pharmacies: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 28. Retail Pharmacies: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 29. Online Pharmacies: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 30. South & Central America Prescription Drugs Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 31. Brazil: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 32. Argentina: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 33. Rest of South & Central America: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 34. Company Positioning & Concentration
Figure 1. South & Central America Prescription Drugs Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. South & Central America Prescription Drugs Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. South & Central America Prescription Drugs Market Revenue (US$ Billion), 2024 - 2031
Figure 7. South & Central America Prescription Drugs Market Share (%) - by Product Type, 2024 and 2031
Figure 8. Branded: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 9. Generics: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 10. South & Central America Prescription Drugs Market Share (%) - by Drug Type, 2024 and 2031
Figure 11. Small Molecule: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 12. Biologics and Biosimilar: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 13. South & Central America Prescription Drugs Market Share (%) - by Therapeutic Area, 2024 and 2031
Figure 14. Oncology: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 15. Cardiovascular Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 16. Neurological Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 17. Metabolic Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 18. Respiratory Diseases: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 19. Immunology: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 20. Others: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 21. South & Central America Prescription Drugs Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 22. Oral: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 23. Injectable: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 24. Topical: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 25. Others: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 26. South & Central America Prescription Drugs Market Share (%) - by Distribution Channel, 2024 and 2031
Figure 27. Hospital Pharmacies: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 28. Retail Pharmacies: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 29. Online Pharmacies: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 30. South & Central America Prescription Drugs Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 31. Brazil: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 32. Argentina: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 33. Rest of South & Central America: South & Central America Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 34. Company Positioning & Concentration
